Tyra Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TYRA and other ETFs, options, and stocks.

About TYRA

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies.

CEO

Todd J. Harris

CEOTodd J. Harris

Employees

Employees60

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

2018

Founded2018

Employees

Employees60

TYRA Key Statistics

Market cap

1.23B

Market cap1.23B

Price-Earnings ratio

-12.23

Price-Earnings ratio-12.23

Dividend yield

—

Dividend yield—

Average volume

431.23K

Average volume431.23K

High today

$23.39

High today$23.39

Low today

$22.61

Low today$22.61

Open price

$22.71

Open price$22.71

Volume

414.10K

Volume414.10K

52 Week high

$24.05

52 Week high$24.05

52 Week low

$6.42

52 Week low$6.42

Stock Snapshot

As of today, Tyra Biosciences(TYRA) shares are valued at $22.99. The company's market cap stands at 1.23B, with a P/E ratio of -12.23.

On 2025-12-18, Tyra Biosciences(TYRA) stock traded between a low of $22.61 and a high of $23.39. Shares are currently priced at $22.99, which is +1.7% above the low and -1.7% below the high.

The Tyra Biosciences(TYRA)'s current trading volume is 414.1K, compared to an average daily volume of 431.23K.

During the past year, Tyra Biosciences(TYRA) stock moved between $6.42 at its lowest and $24.05 at its peak.

Analyst ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own TYRA. This list is generated using Robinhood data, and it’s not a recommendation.